This study aimed to evaluate the predictive performance of integrated clinical and CT-based radiomic models for assessing targeted therapy efficacy in advanced lung adenocarcinoma patients with EGFR (epidermal growth factor receptor) mutations. The gene discussed is EGFR; the disease is lung adenocarcinoma.